Allelic imbalances in endometrial stromal neoplasms: Frequent genetic alterations in the nontumorous normal-appearing endometrial and myometrial tissues

Gynecologic Oncology

Volumn 95, Issue 3, 2004, Pages 662-671

  Moinfar, Farid ^a   Kremser, Marie Luise ^a   Man, Yan Gao ^b   Zatloukal, Kurt ^a   Tavassoli, Fattaneh A ^c   Denk, Helmut ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endometrial stromal sarcoma; Genetic alterations in microenvironmental tissues; Loss of heterozygosity; PTEN

Indexed keywords

DNA MARKER;

ALLELE; ARTICLE; BENIGN TUMOR; CHROMOSOME 10Q; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME 2P; CHROMOSOME 3P; CHROMOSOME 5Q; CLINICAL ARTICLE; DNA POLYMORPHISM; ENDOMETRIUM CANCER; EPITHELIUM CELL; FEMALE; GENE MUTATION; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MICRODISSECTION; MYOMETRIUM; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SARCOMA; STROMA CELL; TISSUE SECTION; TUMOR CELL; TUMOR SUPPRESSOR GENE; UTERUS PROLAPSE;

ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MYOMETRIUM; PHOSPHORIC MONOESTER HYDROLASES; PTEN PHOSPHOHYDROLASE; SARCOMA, ENDOMETRIAL STROMAL; TUMOR SUPPRESSOR PROTEINS;

EID: 9944266192     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.08.016     Document Type: Article

References (42)

1. L.G. Koss, R.H. Spiro, and A. Brunschwig Endometrial stromal sarcoma Surg. Gynecol. Obstet. 121 1965 531 537
2. L.A. Aaro, R.E. Symmonds, and M.B. Dockertly Sarcoma of the uterus. A clinical and pathologic study of 117 cases Am. J. Obstet. Gynecol. 94 1966 101 109
3. H.J. Norris, and H.B. Taylor Mesenchymal tumors of the uterus. I. A clinical and pathological study of 53 endometrial stromal tumors Cancer 19 1966 755 766
4. F.A. Tavassoli, and P. Devilee World Health Organization classification of tumours. Pathology & Genetics of Tumors of the Breast and Female Genital Organs 2003 IARCP Press Lyon
5. C. Sreekantaiah, F.P. Li, N. Weidner, and A. Sandberg An endometrial stromal sarcoma with clonal cytogenetic abnormalities Cancer Genet. Cytogenet. 55 1991 163 166
6. P. Dal Cin, M.S. Aly, I. De Wever, P. Moerman, and H. Van Den Berghe Endometrial stromal sarcoma t(7;17)(p15-21;q12-21) is a common non-random chromosome change Cancer Genet. Cytogenet. 63 1992 43 46
7. R. Laxman, J.L. Currie, R.J. Kurmann, M. Dudzinski, and C.A. Griffin Cytogenetic profile of uterine sarcomas Cancer 71 1993 1283 1288
8. A.N. Cheung, V.P. Tin, H.Y. Ngan, L.P. Chung, and U.S. Khoo Interphase cytogenetic study of endometrial stromal sarcoma by chromosome in situ hybridization Mod. Pathol. 9 1996 910 918
9. J.I. Koontz, A.L. Soreng, M. Nucci, F.C. Kuo, P. Pauwels, H. Van den Berghe, P.D. Cin, J.A. Fletcher, and J. Sklar Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors Proc. Natl. Acad. Sci. 98 2001 6348 6353
10. H.Y. Huang, M. Ladanyi, and R.A. Soslow Molecular detection of JAZF1 and JJAZ1 gene fusion in endometrial stromal neoplasms with classic and variant histology: evidence for genetic heterogeneity Am. J. Surg. Pathol. 28 2004 224 232
11. F. Moinfar, Y.G. Man, G.L. Bratthauer, M. Ratschek, and F.A. Tavassoli Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ("clinging ductal carcinoma in situ"): a simulator of normal mammary epithelium Cancer 88 2000 2072 2081
12. F. Moinfar, Y.G. Man, L. Arnould, G.L. Bratthauer, M. Ratschek, and F.A. Tavassoli Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis Cancer Res. 60 2000 2562 2566
13. Y.L. Zhai, T. Nikaido, A. Orii, A. Horiuchi, T. Toki, and S. Fujii Frequent occurrence of loss of heterozygosity among tumor suppressor genes in uterine leiomyosarcoma Gynecol. Oncol. 75 1999 453 459
14. D. Tritz, M. Pieretti, S. Turner, and D. Powell Loss of heterozygosity in usual and special variant carcinomas of the endometrium Hum. Pathol. 28 1997 607 612
15. S. Katsuyasu, O. Masaki, and H. Miki Microsatellite alterations in various sarcomas in Japanese patients J. Orthoo. Sci. 4 1999 223 230
16. L. Cawkwell, S.M. Bell, F.A. Lewis, M.F. Dixon, G.R. Taylor, and P. Quirke Rapid detection of allele loss in colorectal tumors using microsatellites and fluorescent DNA technology Br. J. Cancer 67 1993 1262 1267
17. H. Tashiro, M.S. Blazes, and R. Wu Mutation in PTEN are frequent in endometrial carcinoma but rare in other common gynaecological malignancies Cancer Res. 57 1997 3935 3940
18. E. Bussaglia, E. Rio, X. Matias-Guiu, and J. Prat PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases Hum. Pathol. 31 2000 312 317
19. M.J. Park, M.S. Kim, and I.C. Park PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation Cancer Res. 62 2002 6318 6322
20. C. Eng Role of PTEn, a lipid phosphatase upsteam effector of protein kinase B, in epithelial thyroid carcinogenesis Ann. N. Y. Acad. Sci. 968 2002 213 221
21. K. Kurose, K. Gilly, S. Matsumoto, P.H. Watson, X.P. Zhou, and C. Eng Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of the breast carcinomas Net. Genet. 32 2002 355 357
22. N.D. Deocampo, H. Huang, and D.J. Tindall The role of PTEN in the progression and survival of prostate cancer Minerva Endocrinol. 28 2003 145 153
23. H. WU, V. Goel, and F.G. Haluska PTEN signalling pathways in melanoma Oncogene 22 2002 3113 3122
24. J.M. Stahl, M. Cheung, A. Sharma, N.R. Trivedi, S. Shanmugam, and G.P. Robertson Loss of PTEN promotes development in malignant melanoma Cancer Res. 63 2003 2881 2890
25. T. Saito, Y. Oda, and T. Kawaguchik PTEN/MMAC1 gene mutation is a rare event in soft tissue sarcomas without specific balanced translocations Int. J. Cancer 104 2003 175 178
26. A. Sjöling, E. Samuelson, T. Adamovic, A. Behboudi, D. Röme, and G. Levan Recurrent allelic imbalance at the rat pten locus in DMBA-induce3d fibrosarcoma Genes Chromosomes Cancer 36 2003 70 79
27. O. Gimm, H. Chi, and P.L. Dahia Somatic mutation and germline variants of MINPP1, a phosphatase gene located in proximity to PTEN on 10q23.3, in follicular thyroid carcinomas J. Clin. Endocrinol. 86 2001 1801 1805
28. X.P. Zhou, K. Woodford-Richens, and R. Lehtonen Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes Am. J. Hum. Genet. 69 2001 704 711
29. H.B. Salvesen, N. McDonald, and A. Ryan PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma Int. J. Cancer 91 2001 22 26
30. Y.E. Whang, X. Wu, and H. Suzuki Inactivation of the tumor suppressor PTEN/MMMAC1 in advanced human prostate cancer through loss of expression Proc. Natl. Acad. Sci. 95 1998 5246 5250
31. A. Di Cristofano, B. Pesce, C. Cordon-Cardo, and P. Pandolfi PTEN is essential for embryonic development and tumor suppression Nat. Genet. 19 1998 348 355
32. B. Kwabi-Addo, D. Giri, and K. Schmidt Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression Proc. Natl. Acad. Sci. 98 2001 11563 11568
33. J.T. Dong Chromosomal deletions and tumor suppressor genes in prostate cancer Cancer Metastasis Rev. 20 2001 173 193
34. A. Di Cristofano, and P.P. Pandolfi The multiple roles of PTEN in tumor suppression Cell 100 2002 387 390
35. T. Bando, Y. Kato, Y. Ihara, F. Yamagishi, K. Tsukada, and M. Isobe Loss of heterozygosity of 14q32 in colorectal carcinoma Cancer Genet. Cytogenet. 111 1999 161 165
36. C.A. Bandera, H. Takahashi, and K. Behbakht Deletion mapping of two potential chromosome 14 tumor suppressor gene loci in ovarian carcinoma Cancer Res. 57 1997 513 515
37. Y. Ihara, Y. Kato, and T. Bando Allelic imbalance of 14q32 in esophageal carcinoma Cancer Genet. Cytogenet. 135 2002 177 181
38. T.E. Petursdottir, S.H. Hafsteinsdottir, and J.G. Jonasson Loss of heterozygosity at the FHIT gene in different solid human tumors and its association with survival in colorectal cancer patients Anticancer Res. 22 2002 3205 3212
39. K. Ozaki, T. Enomoto, and K. Yoshino Fhit alterations in endometrial carcinoma and hyperplasia Int. J. Cancer 85 2000 306 312
40. C.M. Acevedo, M. Henriquez, M.R. Emmert-Buck, and R.F. Chuagui Loss of heterozygosity on chromosome arms 3p and 6q in microdissected adenocarcinomas of the uterine cervix and adenocarcinoma in situ Cancer 94 2002 793 802
41. M.M. Quezdo, C.A. Moskaluk, B. Bryant, S.E. Mills, and M.J. Merino Incidence of loss of heterozygosity at p53 and BRCA1 loci in serous surface carcinoma Hum. Pathol. 30 1999 203 207
42. M. Sztan, Z. Papai, M. Szendroi, A. Looij, and E. Olah Allelic losses from chromosome 17 in human osteosarcomas Pathol. Oncol. Res. 3 1997 115 120